Dr Michalis Papadakis is the CEO and co-founder of Brainomix, a pioneering AI medical engineering company spun out of the University of Oxford. Under his leadership, Brainomix has grown into a global innovator, securing over $68 million in investment and revolutionalising stroke and lung disease treatment through AI-powered imaging solutions. A recognised academic and entrepreneur, he has forged strong industry partnerships and is committed to advancing healthcare technology to improve patient outcomes worldwide.He has a BSc Honours in Biochemistry from Imperial College London and a PhD in neurosciences from UCL School of Pharmacy.